Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy

Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy

The disadvantages of conventional anticancer drugs, such as their low bioavailability, poor targeting efficacy, and serious side effects, have led to the discovery of new therapeutic agents and potential drug delivery systems. In particular, the introduction of nano-sized drug delivery systems (NDDS...

Full description

Bibliographic Details
Main Authors: Zerrin Sezgin-Bayindir, Sonia Losada-Barreiro, Carlos Bravo-Díaz, Matej Sova, Julijana Kristl, Luciano Saso
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Antioxidants
Subjects:
NRF2 modulators
anticancer agents
nanoparticles
drug delivery
drug targeting
Online Access:https://www.mdpi.com/2076-3921/10/5/685

Internet

https://www.mdpi.com/2076-3921/10/5/685

Similar Items